The Drug Delivery to the Lungs conference (DDL) is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery.
Author profile
ジョン ヘインズワース
Associate Director, Healthcare technologies
John has over twenty years’ experience leading development of advanced DPIs and MDIs, delivering novel aerodynamic, mechanical and electromechanical designs, and providing deep technical leadership in creating next‑generation drug delivery systems.
My insights
RDD (Respiratory Drug Delivery) 2026
This is the latest Respiratory Drug Delivery conference in a series that has run continuously since 1988 and garnered a sustained reputation for excellent content covering all aspects of drug delivery to the lungs and nose.